PP_1170x120_10-25-21

RETEVMO

RETEVMO (selpercatinib) now available at Biologics by McKesson

RETEVMO (selpercatinib) now available at Biologics by McKesson

CARY, N.C. —Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been selected by Eli Lilly and Co. as a specialty pharmacy provider for RETEVMO (selpercatinib), the first drug approved by the U.S. Food and Drug Administration (FDA) specifically for patients with advanced RET-driven non-small cell lung cancer (NSCLC)

Adheris Health